NovoCure Limited Company Profile
NASDAQ: NVCRHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NovoCure at a glance
NovoCure Limited (NASDAQ: NVCR) is a Medical/Dental Instruments company in the Health Care sector headquartered in Baar, Jersey. NovoCure is led by Mr. Frank Leonard and employs about 1,605 people. The company's shares have traded publicly since 2015.
At a market capitalization of $1.66 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001645113, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does NovoCure do?
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Business description based on the company's public filings.
Company information
- Legal name
- NovoCure Limited
- Ticker
- NASDAQ: NVCR
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Frank Leonard
- Employees
- 1,605
- Headquarters
- Neuhofstrasse 21, Baar, Jersey
- Phone
- 44 (0)15 3475 6700
- Website
- novocure.com
- IPO year
- 2015
- Market cap
- $1.66B
- SEC CIK
- 0001645113
- Latest annual report
- 10-K · Feb 26, 2026
Companies similar to NovoCure
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ATECAlphatec Holdings Inc. | 10.35 | +0.98% | $1.60B | vs NVCR |
| XRAYDENTSPLY SIRONA Inc. | 8.69 | +1.76% | $1.73B | vs NVCR |
| KMTSKestra Medical Technologies Ltd. | 25.77 | -2.72% | $1.53B | vs NVCR |
| INSPInspire Medical Systems Inc. | 66.69 | -1.13% | $1.93B | vs NVCR |
| DRTSAlpha Tau Medical Ltd. | 14.00 | -1.75% | $1.29B | vs NVCR |
| IRMDiRadimed Corporation | 85.88 | +0.48% | $1.10B | vs NVCR |
| UFPTUFP Technologies Inc. | 286.56 | -2.15% | $2.22B | vs NVCR |
| TNDMTandem Diabetes Care Inc. | 15.68 | -1.04% | $1.09B | vs NVCR |